methenamine has been researched along with Corneal Dystrophies in 1 studies
Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johannsson, JH | 1 |
| Jonasson, F | 1 |
1 other study available for methenamine and Corneal Dystrophies
| Article | Year |
|---|---|
Methenamine-silver staining in macular corneal dystrophy.
Topics: Cornea; Corneal Dystrophies, Hereditary; Humans; Macula Lutea; Methenamine; Retinal Diseases; Silver | 1988 |